<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32976566</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1759-4685</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of molecular cell biology</Title><ISOAbbreviation>J Mol Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>28</EndPage><MedlinePgn>15-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jmcb/mjaa049</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease selectively affecting motor neurons, leading to progressive paralysis. Although most cases are sporadic, &#x223c;10% are familial. Similar proteins are found in aggregates in sporadic and familial ALS, and over the last decade, research has been focused on the underlying nature of this common pathology. Notably, TDP-43 inclusions are found in almost all ALS patients, while FUS inclusions have been reported in some familial ALS patients. Both TDP-43 and FUS possess 'low-complexity domains' (LCDs) and are considered as 'intrinsically disordered proteins', which form liquid droplets in vitro due to the weak interactions caused by the LCDs. Dysfunctional 'liquid-liquid phase separation' (LLPS) emerged as a new mechanism linking ALS-related proteins to pathogenesis. Here, we review the current state of knowledge on ALS-related gene products associated with a proteinopathy and discuss their status as LLPS proteins. In addition, we highlight the therapeutic potential of targeting LLPS for treating ALS.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2020). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pakravan</LastName><ForeName>Donya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB-KU Leuven Center for Brain &amp; Disease Research, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orlando</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Switch Laboratory, VIB-KU Leuven Center for Brain &amp; Disease Research, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bercier</LastName><ForeName>Val&#xe9;rie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB-KU Leuven Center for Brain &amp; Disease Research, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB-KU Leuven Center for Brain &amp; Disease Research, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Cell Biol</MedlineTA><NlmUniqueID>101503669</NlmUniqueID><ISSNLinking>1759-4685</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064267">Intrinsically Disordered Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064267" MajorTopicYN="N">Intrinsically Disordered Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016376" MajorTopicYN="N">Oligonucleotides, Antisense</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS therapy</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">phase separation</Keyword><Keyword MajorTopicYN="N">stress granule</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32976566</ArticleId><ArticleId IdType="pmc">PMC8036000</ArticleId><ArticleId IdType="doi">10.1093/jmcb/mjaa049</ArticleId><ArticleId IdType="pii">5911632</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramzon Y., Johnson J.O., Scholz S.,. et al. (2012). Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2231.e1&#x2013;2231.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391327</ArticleId><ArticleId IdType="pubmed">22572540</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.-M., Ernst P., et al. (2017). Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 8, 45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa H., Sawada J., Hideyama T., et al. (2010). TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol. 120, 75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">20372915</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., et al. (2014). Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 13, 1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M.K., St&#xe5;hlberg A., Arvidsson Y., et al. (2008). The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 9, 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., et al. (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Zago P., D&#x2019;Ambrogio A., et al. (2008). Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci.&#xa0;121, 3778&#x2013;3785.</Citation><ArticleIdList><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthavachalu B., Huelsmeier J., Sudhakaran I.P., et al. (2018). RNP-granule assembly via Ataxin-2 disordered domains is required for long-term memory and neurodegeneration. Neuron 98, 754&#x2013;766.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">29772202</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. (2018). C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14, 544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., et al. (2017). Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544, 367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio E.H., Wu J.Y., Deng H.X., et al. (2013). Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol. 125, 463&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593646</ArticleId><ArticleId IdType="pubmed">23378033</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanc R.S., Richard S. (2017). Arginine methylation: the coming of age. Mol. Cell 65, 8&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">28061334</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J.N., Koppers M., et al. (2013). Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 25, 777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehringer A., Garcia-Mansfield K., Singh G., et al. (2017). ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci. Rep. 7, 14529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5674072</ArticleId><ArticleId IdType="pubmed">29109432</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., et al. (2017). Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell 65, 1044&#x2013;1055.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., et al. (2016). Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 6, 20877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., et al. (2018). Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep. 24, 529&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B., Faure A.J., Seuma M., et al. (2019). The mutational landscape of a prion-like domain. Nat. Commun. 10, 4162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne C.P. (2013). Phase transitions and size scaling of membrane-less organelles. J. Cell Biol. 203, 875&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3871435</ArticleId><ArticleId IdType="pubmed">24368804</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Stem Yilmaz R., M&#xfc; Ller K., et al. (2018). Hot-spot KIF5A mutations cause familial ALS. Brain 141, 688&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. (2017). Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S, et al. (1998). Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851&#x2013;1854.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J.R., Kolaitis R.M., Taylor J.P., et al. (2013). Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Giombi M., et al. (2005). TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572&#x2013;37584.</Citation><ArticleIdList><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R.J. (2019). Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 137, 859&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke K.A., Janke A.M., Rhine C.L.,. et al. (2015). Residue-by-residue view of&#xa0;in vitro&#xa0;FUS granules that bind the C-terminal domain of RNA polymerase II. Mol. Cell 60, 231&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. (2019). RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 9, 712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;a&#x11f;atay T., Chook Y.M. (2018). Karyopherins in cancer. Curr. Opin. Cell Biol. 52, 30&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5988925</ArticleId><ArticleId IdType="pubmed">29414591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhury A., Hussey G.S., Ray P.S., et al. (2010). TGF-&#x3b2;-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat. Cell Biol. 12, 286&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2830561</ArticleId><ArticleId IdType="pubmed">20154680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.Y.S., Shin H.R., Berdan C.A., et al. (2019). Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition. Nat. Chem. Biol. 15, 776&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6641988</ArticleId><ArticleId IdType="pubmed">31285595</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., et al. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Restrepo C.R., et al. (2015). An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 6, 5845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., et al. (2009). TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J., et al. (2016). ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24, 1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Erion R., et al. (2012). Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2899&#x2013;2911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouisa J., Harta M.P., Shorter J., et al. (2011). A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl Acad. Sci. USA 108, 20881&#x2013;20890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Kolaitis R.M., Kim H.J., et al. (2018). Ubiquitin modulates liquid&#x2013;liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell 69, 965&#x2013;978.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Hafezparast M. (2017). Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol. Dis. 105, 283&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. (2014a). The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 10, 337&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Hentati A., Tainer J.A., et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Holler C.J., Taylor G., et al. (2014b). FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J. Neurosci. 34, 7802&#x2013;7813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., et al. (2011). TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 31, 1098&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., et al. (2012). TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res. 1462, 16&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., et al. (2012). Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 31, 4258&#x2013;4275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 29, 2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., et al. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M.Y., Markmiller S., Vu A.Q., et al. (2019). Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron 103, 802&#x2013;819.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y.S., Tsai K.J., Chang Y.J., et al. (2014). Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat. Commun. 5, 4824.</Citation><ArticleIdList><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan S.M.K., Howrigan D.P., Abbott L.E., et al. (2019). Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat. Neurosci. &#xa0;22, 1966&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., et al. (2015). Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 5, 13416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla A.-M., Rousseau F., Schymkowitz J., et al. (2004). Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22, 1302&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., et al. (2015). GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., et al. (2015). Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L., Young F.L., Boeynaems S., et al. (2019). C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. bioRxiv, 10.1101/835082</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/835082</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganassi M., Mateju D., Bigi I., et al. (2016). A surveillance function of the HSPB8&#x2013;BAG3&#x2013;HSP70 chaperone complex ensures stress granule integrity and dynamism. Mol. Cell 63, 796&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">27570075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., et al. (2019). Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., Kaunga E., Ye J., et al. (2020). The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106, 789&#x2013;805.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Geahlen R.L. (2015). Stress granules modulate SYK to cause microglial cell dysfunction in Alzheimer&#x2019;s disease. EBioMedicine 2, 1785&#x2013;1798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4740304</ArticleId><ArticleId IdType="pubmed">26870803</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Mossevelde S., Van Der Zee J., et al. (2016). The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry 21, 1112&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4960451</ArticleId><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Shorter J. (2011). RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5, 179&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226045</ArticleId><ArticleId IdType="pubmed">21847013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings L.M., Boeynaems S., Lightwood D., et al. (2020). Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity. Acta Neuropathol. 139, 407&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6989575</ArticleId><ArticleId IdType="pubmed">31832771</ArticleId></ArticleIdList></Reference><Reference><Citation>Guill&#xe9; N-Boixet J., Kopach A., Holehouse A.S., et al. (2020). RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell 181, 346&#x2013;361.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181197</ArticleId><ArticleId IdType="pubmed">32302572</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Kim H.J., Wang H., et al. (2018). Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell 173, 677&#x2013;692.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Stoklund Dittlau K., Van Den Bosch L. (2019). Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin. Cell Dev. Biol. 99, 133&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., et al. (2012). Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 149, 768&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., et al. (2008). Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J., Catanese A., Semelink-Sedlacek L.L., et al. (2018). NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 30, 150&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi M., Maas S., Single F.N., et al. (2000). Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406, 78&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">10894545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., et al. (2016). UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell 166, 935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., et al. (2018). Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell 173, 706&#x2013;719.e13.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman A.A., Weber C.A., J&#xfc;licher F. (2014). Liquid&#x2013;liquid phase separation in biology. Ann. Rev. Cell Dev. Biol. 30, 39&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Xu Y., et al. (2008). Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiura H., Tsuji S. (2015). Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72. J. Neurogenet. 29, 85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26540641</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S., Subramanian V., Acharya K.R. (2018). C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ 6, e5815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195791</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Wheeler J.R., Walters R.W., et al. (2016). ATPase-modulated stress granules contain a diverse proteome and substructure. Cell 164, 487&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Zhu Q., Gendron T.F., et al. (2016). Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 90, 535&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., et al. (2009). TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329&#x2013;20339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Pioro E.P., Boehringer A., et al. (2014). Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaehler C., Isensee J., Nonhoff U., et al. (2012). Ataxin-2-like is a regulator of stress granules and processing bodies. PLoS One 7, e50134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3507954</ArticleId><ArticleId IdType="pubmed">23209657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada M., Izumi Y., Ayaki T., et al. (2014). Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathology 34, 64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">23889540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., et al. (2012). Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149, 753&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Yang Y.S., Sutter B.M., et al. (2019). Redox state controls phase separation of the yeast ataxin-2 protein via reversible oxidation of its methionine-rich low-complexity domain. Cell 177, 711&#x2013;721.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752730</ArticleId><ArticleId IdType="pubmed">30982603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha, N.,, and&#xa0;Anderson,&#xa0;P. ( 2007). Mammalian stress granules and processing bodies. Methods&#xa0;Enzymol. 431, 61&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17923231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha, N.,&#xa0;and, Anderson, P.&#xa0;(2002) Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 30, 963&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">12440955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Cho M.R., Li W., et al. (2000). Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 151, 1257&#x2013;1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190599</ArticleId><ArticleId IdType="pubmed">11121440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., Van Doormaal P.T.C., Dekker A.M., et al. (2016). NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 48, 1037&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.D., et al. (2013). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim J.R., Williams L.A., Limone F., et al. (2019). ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar Rai A., Chen J.-X., Selbach M., et al. (2018). Kinase-controlled phase transition of membraneless organelles in mitosis. Nature 559, 211&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">29973724</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Kato M., Xiang S., et al. (2013). Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell 155, 1049&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010232</ArticleId><ArticleId IdType="pubmed">24267890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong L.K., Irwin D.J., Walker A.K., et al. (2014). Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins. Acta Neuropathol. Commun. 2, 33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023626</ArticleId><ArticleId IdType="pubmed">24690345</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao, Y.-C., Fernandopulle M.S., Wang G., et al. (2019). RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether. Cell 179, 147&#x2013;164.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890474</ArticleId><ArticleId IdType="pubmed">31539493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Zhang P., Kim H.J., et al. (2016). C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167, 774&#x2013;788.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T., Li Y.R., Ingre C., et al. (2011). Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum. Mol. Genet. 20, 1697&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071667</ArticleId><ArticleId IdType="pubmed">21292779</ArticleId></ArticleIdList></Reference><Reference><Citation>Y., Protter, et al. (2015). Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell 60, 208&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., et al. (2010). Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5, e13250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhang S., Gu J., et al. (2020). Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat. Struct. Mol. Biol. 27, 363&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">32231288</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. (2019). Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr. Opin. Neurol. 32, 771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., et al. (2017). TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron 95, 808&#x2013;816.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S., Wang J., Papadopoulos D.K., et al. (2018). RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E., Renton A.E., Mok K., et al. (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 11, 323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., et al. (2019). RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321&#x2013;338.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S., Soltanieh S., Server K.L., et al. (2018). Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell 172, 590&#x2013;604.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., et al. (2019). FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 138, 67&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., et al. (2010). Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., et al. (2011). TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 20, 1400&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Gomes E., Guo L., et al. (2018). Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell 71, 703&#x2013;717.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z., L&#xf3;pez-Erauskin J., Baughn M.W., et al. (2019). Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Pestronk A., David W., et al. (2013). An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 12, 435&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., et al. (2015). Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., et al. (2017). Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 36, 2951&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S., Alsop E., Lorenzini I., et al. (2019). ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD. Acta Neuropathol. 138, 49&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6750285</ArticleId><ArticleId IdType="pubmed">30945056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.M., Arzberger T., et al. (2013). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339, 1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Bentmann E., Dormann D., et al. (2011). FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134, 2595&#x2013;2609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Lee E.B., et al. (2009a). Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., et al. (2009b). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. (2018). ALS genes in the genomic era and their implications for FTD. Trends Genet. 34, 404&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., et al. (2018). Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97, 1268&#x2013;1282.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Suzuki G., Tanaka Y., et al. (2016). Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1&#x3b4; triggers mislocalization and accumulation of TDP-43. J. Biol. Chem. 291, 5473&#x2013;5483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhoff U., Ralser M., Welzel F., et al. (2007). Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell 18, 1385&#x2013;1396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1838996</ArticleId><ArticleId IdType="pubmed">17392519</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando G., Raimondi D., Tabaro F., et al. (2019.). Computational identification of prion-like RNA-binding proteins that form liquid phase-separated condensates. Bioinformatics 35, 4617&#x2013;4623.</Citation><ArticleIdList><ArticleId IdType="pubmed">30994888</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., et al. (2015). A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul K.R., Molliex A., Cascarina S., et al. (2017). Effects of mutations on the aggregation propensity of the human prion-like protein hnRNPA2B1. Mol. Cell. Biol. 37, e00652-16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376634</ArticleId><ArticleId IdType="pubmed">28137911</ArticleId></ArticleIdList></Reference><Reference><Citation>Penndorf D., Witte O.W., Kretz A. (2018). DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen. Res. 13, 173&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5879878</ArticleId><ArticleId IdType="pubmed">29557356</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter, D.S.W.,&#xa0;and, Parker R.&#xa0;(2016) . Principles and properties of stress granules. Trends Cell Biol. 26,&#xa0;668&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Hart P.J., Borchelt D.R., et al. (2009). Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum. Mol. Genet. 18, 3217&#x2013;3226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., et al. (2018). FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell 173, 720&#x2013;734.e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. (2016). Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 138, 95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reijns, M.A.M.,, Alexander, R.D.,, Spiller, M.P., et&#xa0;al.&#xa0;(2008). A role for Q/N-rich aggregation-prone regions in P-body localization. J. Cell Sci. 121, 2463&#x2013;2472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680509</ArticleId><ArticleId IdType="pubmed">18611963</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L., Picher-Martel V., Codron P., et al. (2019). Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. Commun. 7, 103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan V.H., Dignon G.L., Burke K.A. (2018). Mechanistic view of hnRNPA2 low-complexity domain structure, interactions, and phase separation altered by mutation and arginine methylation. Mol. Cell 69, 465&#x2013;479.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801700</ArticleId><ArticleId IdType="pubmed">29358076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders D.W., Kedersha N., Lee D.S.W., et al. (2020). Competing protein&#x2212;RNA interaction networks control multiphase intracellular organization. Cell 181, 306&#x2013;324.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816278</ArticleId><ArticleId IdType="pubmed">32302570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansam C.L., Wells K.S., Emeson R.B. (2003). Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc. Natl Acad. Sci. USA 100(Suppl. 2), 14018&#x2013;14023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283538</ArticleId><ArticleId IdType="pubmed">14612560</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B., Rohatgi R. (2016). In vivo formation of vacuolated multi-phase compartments lacking membranes. Cell Rep. 16, 1228&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972689</ArticleId><ArticleId IdType="pubmed">27452472</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Wang X., Podell E.R., et al. (2013). RNA seeds higher-order assembly of FUS protein. Cell Rep. 5, 918&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoles D.R., Meera P., Schneider M.D., et al. (2017). Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature 544, 362&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625650</ArticleId><ArticleId IdType="pubmed">28405024</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary E.R., Sison S.L., Ebert A.D. (2018). Modeling protein aggregation and the heat shock response in ALS iPSC-derived motor neurons. Front. Neurosci. 12, 86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalom O., Shalva N., Altschuler Y., et al. (2008). The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett. 582, 1465&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">18387364</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K.Y., Mori E., Nizami Z.F., et al. (2017). Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl Acad. Sci. USA 114, E1111&#x2013;E1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. (2016). Engineering therapeutic protein disaggregases. Mol. Biol. Cell 27, 1556&#x2013;1560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4865313</ArticleId><ArticleId IdType="pubmed">27255695</ArticleId></ArticleIdList></Reference><Reference><Citation>Singatulina A.S., Hamon L., Sukhanova M.V., et al. (2019). PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 27, 1809&#x2013;1821.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31067465</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, B.N., Topp S.D., Fallini C.,. et al. (2017). Mutations in the vesicular trafficking protein Annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med. 9, eaad9157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. (2019). The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 710, 132933.</Citation><ArticleIdList><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J., Scheveneels W., Vanneste J., et al. (2018). FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet. 27, 4103&#x2013;4116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Calvet M., Neumann M., Arzberger T., et al. (2016). Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathol. 131, 587&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">26895297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Wu R., Zheng J., et al. (2018). Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 28, 405&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939046</ArticleId><ArticleId IdType="pubmed">29507397</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M., Doi H., Koyano S., et al. (2018). Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am. J. Pathol. 188, 507&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F., Ronchi D., Magri F., et al. (2015). SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front. Cell. Neurosci. 9, 336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. (2016). Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Trendel J., Schwarzl T., Horos R., et al. (2019). The human RNA-binding proteome and its dynamics during translational arrest. Cell 176, 391&#x2013;403.e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">30528433</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Luisier R., Taha D.M., et al. (2019). Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain 142, 2572&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Urdaneta E.C., Vieira-Vieira C.H., Hick T., et al. (2019). Purification of cross-linked RNA-protein complexes by phenol-toluol extraction. Nat. Commun. 10, 990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397201</ArticleId><ArticleId IdType="pubmed">30824702</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Spek R.A., van Rheenen W., Pulit S.L., et al. (2018). Reconsidering the causality of TIA1 mutations in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6516059</ArticleId><ArticleId IdType="pubmed">29235362</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., et al. (2019). C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci. Rep. 9, 15728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh I., Seno F., Tosatto S.C.E., et al. (2014). PASTA 2.0: an improved server for protein aggregation prediction. Nucleic Acids Res. 42, 301&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086119</ArticleId><ArticleId IdType="pubmed">24848016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.Y., Pan L., Su S.C., et al. (2013). Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 16, 1383&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler R.J., Lee H.O., Poser I., et al. (2019). Small molecules for modulating protein driven liquid&#x2013;liquid phase separation in treating neurodegenerative disease. bioRxiv, 10.1101/721001</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/721001</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., et al. (2008). Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302&#x2013;13309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. (2014). Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease. Discov. Med. 17, 47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4694572</ArticleId><ArticleId IdType="pubmed">24411700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., et al. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.H., Fallini C., Ticozzi N., et al. (2012). Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488, 499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang S., Kato M., Wu L.C.., et al. (2015). The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163, 829&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4879888</ArticleId><ArticleId IdType="pubmed">26544936</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Mathieu C., Kolaitis R.M., et al. (2020). G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell 181, 325&#x2013;345.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.S., Kato M., Wu X., et al. (2019). Yeast ataxin-2 forms an intracellular condensate required for the inhibition of TORC1 signaling during respiratory growth. Cell 177, 697&#x2013;710.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752053</ArticleId><ArticleId IdType="pubmed">30982600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T., Ali R., Jiou J., et al. (2018). Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell 173, 693&#x2013;705.e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn, J.-Y., , Dyakov, B.J.A.,, Zhang, J.,&#xa0;et&#xa0;al.&#xa0;(2019) . Properties of stress granule and P-body proteomes. Mol. Cell 76,&#xa0;286&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">31626750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., et al. (2018). Stress granule assembly disrupts nucleocytoplasmic transport. Cell 173, 958&#x2013;971.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., et al. (2015). The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Fan B., Yang P., et al. (2019). Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. eLife 8, e39578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Xu Y.F., Cook C., et al. (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607&#x2013;7612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.C., Chook Y.M. (2012). Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS). Proc. Natl Acad. Sci. USA 109, 12017&#x2013;12021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>